Publications by authors named "Jon Inglefield"

Claim this Profile
F
Free interleukin-18 is elevated in CD22 CAR T-cell-associated hemophagocytic lymphohistiocytosis-like toxicities.
Joseph M Rocco, Jon Inglefield, Bonnie Yates, Daniel A Lichtenstein, Yanyu Wang

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability.
Elizabeth K Graydon, Tonia L Conner, Kim Dunham, Cara Olsen, Emilie Goguet, Jon Inglefield

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL-HBV and REVEAL-HCV cohort studies.
Jessica L Petrick, Andrea A Florio, Jane Zen, Yanyu Wang, Andrew T Gewirtz, Jon Inglefield

Int J Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity.
Jennifer Jess, Bonnie Yates, Alina Dulau-Florea, Kevin Parker, Jon Inglefield

J Immunother Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-specific antibody assays and cellular assays.
Jon Inglefield, Jason Catania, Andrea Harris, Thomas Hickey, Zhidong Ma

Vaccine· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR.
Haneen Shalabi, Haiying Qin, Angela Su, Bonnie Yates, Pamela L Wolters, Jon Inglefield

Blood· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells.
Daniel A Lichtenstein, Fiorella Schischlik, Lipei Shao, Seth M Steinberg, Bonnie Yates, Jon Inglefield

Blood· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy.
Hoyoung M Maeng, Brittni N Moore, Hadi Bagheri, Seth M Steinberg, Jon Inglefield

Front Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the AV7909 Anthrax Vaccine Toxicity in Sprague Dawley Rats Following Three Intramuscular Administrations.
Veena V Rao, C Steven Godin, Michael J Lacy, Jon R Inglefield, Sukjoon Park

Int J Toxicol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consequences of hemophagocytic lymphohistiocytosis-like cytokine release syndrome toxicities and concurrent bacteremia.
Katherine E Masih, John A Ligon, Bonnie Yates, Haneen Shalabi, Lauren Little, Jon Inglefield

Pediatr Blood Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses.
Nutan Mytle, Sonja Leyrer, Jon R Inglefield, Andrea M Harris, Thomas E Hickey

Viruses· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909).
Jacob T Minang, Jon R Inglefield, Andrea M Harris, Janet L Lathey, David G Alleva

Vaccine· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR7 agonist 852A inhibition of tumor cell proliferation is dependent on plasmacytoid dendritic cells and type I IFN.
Jon R Inglefield, Calin Dan Dumitru, Sefik S Alkan, Sheila J Gibson, Kenneth E Lipson

J Interferon Cytokine Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
Tarun K Ghosh, Dan J Mickelson, Jonathan C Solberg, Kenneth E Lipson, Jon R Inglefield

Int Immunopharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apoptotic responses in squamous carcinoma and epithelial cells to small-molecule toll-like receptor agonists evaluated with automated cytometry.
Jon R Inglefield, Christopher J Larson, Sheila J Gibson, Hervé Lebrec, Richard L Miller

J Biomol Screen· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
Tarun K Ghosh, Dan J Mickelson, Jason Fink, Jonathan C Solberg, Jon R Inglefield

Cell Immunol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis